Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

1,630 public trials 214 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

NCT01647971

Conditions
B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +33 more
Locations
  • TG Therapeutics Investigational Trial Site Huntsville, Alabama, United States
  • TG Therapeutics Investigational Trial Site Jonesboro, Arkansas, United States
  • TG Therapeutics Investigational Trial Site Athens, Georgia, United States
  • TG Therapeutics Investigational Trial Site Macon, Georgia, United States
View Trial Details
Completed

A Study of PRT1419 in Patients With Relapsed/Refractory Hematologic Malignancies

NCT04543305

Conditions
Acute Myeloid Leukemia, Blood Protein Disorders, Bone Marrow Diseases, +22 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Florida Cancer Specialists Lake Mary, Florida, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

Study to Assess if ABP798 is Safe & Effective in Treating Non Hodgkin Lymphoma Compared to Rituximab

NCT02747043

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • Research Site Encinitas, California, United States
  • Research Site Mount Sterling, Kentucky, United States
  • Research Site Billings, Montana, United States
  • Research Site Zanesville, Ohio, United States
View all 98 locations
View Trial Details
Completed

Study of Venetoclax Plus DA-EPOCH-R for the Treatment of Aggressive B-Cell Lymphomas

NCT03036904

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, High Grade B-Cell Lymphoma, +10 more
Locations
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Weill Cornell Medicine New York, United States
  • Ohio State University Medical Center Columbus, Ohio, United States
View Trial Details

Related conditions